Synthetic lethality is a powerful approach to study selective cell killing based on genotype. We show that loss of Rad52 function is synthetically lethal with breast cancer 2, early onset (BRCA2) deficiency, whereas there was no impact on cell growth and viability in BRCA2-complemented cells. The frequency of both spontaneous and double-strand break-induced homologous recombination and ionizing radiation-induced Rad51 foci decreased by 2-10 times when Rad52 was depleted in BRCA2-deficient cells, with little to no effect in BRCA2-complemented cells. The absence of both Rad52 and BRCA2 resulted in extensive chromosome aberrations, especially chromatid-type aberrations. Ionizing radiation-induced and S phase-associated Rad52-Rad51 foci form equally well in the presence or absence of BRCA2, indicating that Rad52 can respond to DNA double-strand breaks and replication stalling independently of BRCA2. Rad52 thus is an independent and alternative repair pathway of homologous recombination and a target for therapy in BRCA2-deficient cells.DNA repair | genetic instability | chromosomal aberrations D NA double-strand breaks (DSBs) are potentially lethal DNA lesions which may arise spontaneously during DNA replication or result from exposure to ionizing radiation or other DNAdamaging agents (1). To repair DSBs, eukaryotes have developed two DSB repair pathways: nonhomologous end joining and homologous recombination (HR) (2). HR is required for the repair of complex double-strand lesions such as crosslinks or one-ended DSBs that occur with a cleaved replication fork; nonhomologous end joining appears to have little role in the repair of these lesions. The absence of Rad51 in proliferating cells (and therefore any measurable HR) results in cell lethality. The loss of function of proteins involved in HR, such as breast cancer 2, early onset (BRCA2), will be viable only if there is a BRCA2-independent pathway for Rad51 function.In Saccharomyces cerevisiae, the Rad52 protein plays a key role in HR (3). However, in vertebrates, knockouts of the Rad52 gene show little phenotype, with no obvious defect in HR. Rad52 knockout mice exhibit a nearly normal phenotype, and Rad52-deficient embryonic stem cells are not hypersensitive to agents that induce DSBs, either simple or complex (4, 5). In contrast, Rad51 knockout is embryonically lethal (6, 7), and depletion of Rad51 from vertebrate cells results in an accumulation of chromosome aberrations and subsequent cell death (8). These findings indicate the essential role of Rad51 in the maintenance of chromosomal DNA during the mitotic cell cycle, but the role for Rad52 in vertebrate cells is unclear.Accumulating evidence implicates BRCA2 as an integral component of the HR machinery via the direct regulation of the assembly of Rad51 filaments and its subsequent activity in strand exchange (9-11). Biochemical studies showed that the Ustilago maydis BRCA2 ortholog, Brh2, is involved in the recruitment of Rad51 to the sites of HR; Rad51 then mediates the displacement of replication protein A...
The human genetic disorder ataxia-telangiectasia (AT) is characterized by immunodeficiency, progressive cerebellar ataxia, radiosensitivity, cell cycle checkpoint defects and cancer predisposition. The gene mutated in this syndrome, ATM (for AT mutated), encodes a protein containing a phosphatidyl-inositol 3-kinase (PI-3 kinase)-like domain. ATM also contains a proline-rich region and a leucine zipper, both of which implicate this protein in signal transduction. The proline-rich region has been shown to bind to the SH3 domain of c-Abl, which facilitates its phosphorylation and activation by ATM. Previous results have demonstrated that AT cells are defective in the G1/S checkpoint activated after radiation damage and that this defect is attributable to a defective p53 signal transduction pathway. We report here direct interaction between ATM and p53 involving two regions in ATM, one at the amino terminus and the other at the carboxy terminus, corresponding to the PI-3 kinase domain. Recombinant ATM protein phosphorylates p53 on serine 15 near the N terminus. Furthermore, ectopic expression of ATM in AT cells restores normal ionizing radiation (IR)-induced phosphorylation of p53, whereas expression of ATM antisense RNA in control cells abrogates the rapid IR-induced phosphorylation of p53 on serine 15. These results demonstrate that ATM can bind p53 directly and is responsible for its serine 15 phosphorylation, thereby contributing to the activation and stabilization of p53 during the IR-induced DNA damage response.
Recent evidence indicates that arrest of mammalian cells at the G 2 /M checkpoint involves inactivation and translocation of Cdc25C, which is mediated by phosphorylation of Cdc25C on serine 216. Data obtained with a phospho-specific antibody against serine 216 suggest that activation of the DNA damage checkpoint is accompanied by an increase in serine 216 phosphorylated Cdc25C in the nucleus after exposure of cells to ␥-radiation. Prior treatment of cells with 2 mM caffeine inhibits such a change and markedly reduces radiation-induced ataxia-telangiectasia-mutated (ATM)-dependent Chk2/Cds1 activation and phosphorylation. Chk2/Cds1 is known to localize in the nucleus and to phosphorylate Cdc25C at serine 216 in vitro. Caffeine does not inhibit Chk2/Cds1 activity directly, but rather, blocks the activation of Chk2/Cds1 by inhibiting ATM kinase activity. In vitro, ATM phosphorylates Chk2/Cds1 at threonine 68 close to the N terminus, and caffeine inhibits this phosphorylation with an IC 50 of approximately 200 M. Using a phospho-specific antibody against threonine 68, we demonstrate that radiation-induced, ATM-dependent phosphorylation of Chk2/Cds1 at this site is caffeinesensitive. From these results, we propose a model wherein caffeine abrogates the G 2 /M checkpoint by targeting the ATM-Chk2/Cds1 pathway; by inhibiting ATM, it prevents the serine 216 phosphorylation of Cdc25C in the nucleus. Inhibition of ATM provides a molecular explanation for the increased radiosensitivity of caffeine-treated cells.
Recent studies have provided evidence that breast cancer susceptibility gene products (Brca1 and Brca2) suppress cancer, at least in part, by participating in DNA damage signaling and DNA repair. Brca1 is hyperphosphorylated in response to DNA damage and co-localizes with Rad51, a protein involved in homologousrecombination, and Nbs1⅐Mre11⅐Rad50, a complex required for both homologous-recombination and nonhomologous end joining repair of damaged DNA. Here, we report that there is a qualitative difference in the phosphorylation states of Brca1 between ionizing radiation (IR) and UV radiation. Brca1 is phosphorylated at Ser-1423 and Ser-1524 after IR and UV; however, Ser-1387 is specifically phosphorylated after IR, and Ser-1457 is predominantly phosphorylated after UV. These results suggest that different types of DNA-damaging agents might signal to Brca1 in different ways. We also provide evidence that the rapid phosphorylation of Brca1 at Ser-1423 and Ser-1524 after IR (but not after UV)islargelyataxiatelangiectasiamutated(ATM)kinasedependent. The overexpression of catalytically inactive ATM and Rad3 related (ATR) kinase inhibited the UVinduced phosphorylation of Brca1 at these sites, indicating that ATR controls Brca1 phosphorylation in vivo after the exposure of cells to UV light. Moreover, ATR associates with Brca1; ATR and Brca1 foci co-localize both in cells synchronized in S phase and after exposure of cells to DNA-damaging agents. ATR can itself phosphorylate the region of Brca1 phosphorylated by ATM (Ser-Gln cluster in the C terminus of Brca1, amino acids 1241-1530). However, there are additional uncharacterized ATR phosphorylation site(s) between residues 521 and 757 of Brca1. Taken together, our results support a model in which ATM and ATR act in parallel but somewhat overlapping pathways of DNA damage signaling but respond primarily to different types of DNA lesion.Damage to DNA, which can occur from exogenous agents such as IR, 1 UV radiation, and certain chemotherapeutic drugs or from endogenously generated reactive oxygen species, poses a great threat to genomic stability. Cells respond to DNA damage by activating a complex DNA damage-response pathway that includes cell cycle arrest, transcriptional and posttranscriptional regulation of genes associated with repair, and under some circumstances, the triggering of programmed cell death. Biochemically, the DNA damage-response pathway provides a mechanism for transducing a signal from a sensor that recognizes the damage, through a transduction cascade, to a series of downstream effector molecules, which implement the appropriate response. At or close to the top of this pathway in mammalian cells are the members of the phosphoinositide kinase-related kinase (PIKK) family, which includes ATM (ataxia telangiectasia mutated) and ATR (ATM and Rad3 related). These proteins play important roles in signaling the presence of DNA damage, activating cell cycle checkpoints, and repairing DNA (1). ATM is homozygously mutated in the germline of patients with the n...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.